Johansson, Johanna M. https://orcid.org/0000-0002-5090-9701
Du Rietz, Hampus https://orcid.org/0000-0002-5530-3821
Hedlund, Hampus https://orcid.org/0000-0002-3168-7920
Eriksson, Hanna C. https://orcid.org/0000-0002-6652-7177
Oude Blenke, Erik https://orcid.org/0000-0002-0628-3350
Pote, Aditya https://orcid.org/0000-0001-8703-5190
Harun, Said https://orcid.org/0000-0003-0854-0442
Nordenfelt, Pontus https://orcid.org/0000-0002-9481-9951
Lindfors, Lennart
Wittrup, Anders https://orcid.org/0000-0003-4918-0500
Funding for this research was provided by:
Vetenskapsrådet (2020-02647)
Svenska Sällskapet för Medicinsk Forskning
Fru Berta Kamprads Stiftelse (FBKS-2020-33-308, FBKS-2022-40-422)
Gunnar Nilssons Cancerstiftelse
Knut och Alice Wallenbergs Stiftelse (WCMM2019)
Article History
Received: 15 May 2024
Accepted: 10 June 2025
First Online: 1 July 2025
Competing interests
: E.O.B., A.P., S.H. and L.L. were employed by AstraZeneca R&D at the time of this work. The remaining authors declare no competing interests.